Guoxin Hou

820 total citations
33 papers, 578 citations indexed

About

Guoxin Hou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guoxin Hou has authored 33 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guoxin Hou's work include RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer therapeutics and mechanisms (4 papers). Guoxin Hou is often cited by papers focused on RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (6 papers) and Cancer therapeutics and mechanisms (4 papers). Guoxin Hou collaborates with scholars based in China, United States and Australia. Guoxin Hou's co-authors include Panpan Liu, Shijun Wen, Jing Yang, Yumin Hu, Peng Huang, Jianwei Liao, Jing Yang, Yiming Jiang, Jingjing Deng and Wenhao Han and has published in prestigious journals such as PLoS ONE, Environmental Health Perspectives and Gene.

In The Last Decade

Guoxin Hou

28 papers receiving 572 citations

Peers

Guoxin Hou
Zhimin Fan China
Muhammad Tufail China
Fu-Ju Chou United States
Ming You United States
Yongsheng Huang China
Liming Gui China
Dimitra Tsavachidou United States
Chenghui Zhou China
Chee Wai Fhu Singapore
Zhimin Fan China
Guoxin Hou
Citations per year, relative to Guoxin Hou Guoxin Hou (= 1×) peers Zhimin Fan

Countries citing papers authored by Guoxin Hou

Since Specialization
Citations

This map shows the geographic impact of Guoxin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxin Hou more than expected).

Fields of papers citing papers by Guoxin Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxin Hou. The network helps show where Guoxin Hou may publish in the future.

Co-authorship network of co-authors of Guoxin Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxin Hou. A scholar is included among the top collaborators of Guoxin Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxin Hou. Guoxin Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Song, Binbin, et al.. (2024). Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway. Cellular Signalling. 117. 111101–111101. 5 indexed citations
3.
Lu, Zhimin, et al.. (2024). Exploring the function and prognostic value of RPLP0, RPLP1 and RPLP2 expression in lung adenocarcinoma. Journal of Molecular Histology. 55(6). 1079–1091.
4.
Lu, Zhimin, et al.. (2024). Exploring the prognostic and therapeutic value of HIF1A in lung adenocarcinoma. Heliyon. 10(18). e37739–e37739. 1 indexed citations
5.
Lu, Zhimin & Guoxin Hou. (2024). Characterization of the function and clinical value of ERCC family genes in lung adenocarcinoma. Frontiers in Oncology. 14. 1476100–1476100. 1 indexed citations
6.
Hou, Guoxin, et al.. (2022). The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology. Annals of Hepatology. 27(4). 100701–100701. 1 indexed citations
7.
8.
Hou, Guoxin, et al.. (2022). The Mitochondrial Protein C1QBP Promotes Hepatocellular Carcinoma Progression by Enhancing Cell Survival, Migration and Invasion. Journal of Cancer. 13(8). 2477–2489. 6 indexed citations
9.
Lu, Zhimin, et al.. (2022). A pan-cancer analysis of the oncogenic role of ERCC6L. BMC Cancer. 22(1). 1347–1347. 5 indexed citations
10.
Zhang, Ming, Linfeng Cao, Guoxin Hou, Xiaodong Lv, & Jingjing Deng. (2022). Investigation of the Potential Correlation Between RNA-Binding Proteins in the Evolutionarily Conserved MEX3 Family and Non-small-Cell Lung Cancer. Molecular Biotechnology. 65(8). 1263–1274. 5 indexed citations
11.
12.
Ding, Mengmeng, Yongan Li, Zhimin Lu, & Guoxin Hou. (2022). Identification of Potential Immune Checkpoint Inhibitor Targets in Gliomas via Bioinformatic Analyses. BioMed Research International. 2022(1). 1734847–1734847. 5 indexed citations
13.
Deng, Jingjing, Ming Zhang, Hualiang Zhang, et al.. (2021). Value of Growth/Differentiation Factor 15 in Diagnosis and the Evaluation of Chemotherapeutic Response in Lung Cancer. Clinical Therapeutics. 43(4). 747–759. 12 indexed citations
14.
Hou, Guoxin, Jingjing Deng, Jing Chen, et al.. (2020). Mining topoisomerase isoforms in gastric cancer. Gene. 754. 144859–144859. 7 indexed citations
15.
Jiang, Yiming, et al.. (2020). Rapamycin inhibits lung squamous cell carcinoma growth by downregulating glypican-3/Wnt/β-catenin signaling and autophagy. Journal of Cancer Research and Clinical Oncology. 147(2). 499–505. 15 indexed citations
16.
Hou, Guoxin, Panpan Liu, Shengyi Zhang, et al.. (2018). Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis. Cell Death and Disease. 9(2). 89–89. 81 indexed citations
17.
Hou, Guoxin, Panpan Liu, Jing Yang, & Shijun Wen. (2017). Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter. PLoS ONE. 12(3). e0174515–e0174515. 145 indexed citations
18.
Liao, Jianwei, Panpan Liu, Guoxin Hou, et al.. (2017). Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling. Molecular Cancer. 16(1). 51–51. 83 indexed citations
19.
Liu, Lei, et al.. (2016). Protective effect of antioxidant on renal damage caused by doxorubicin chemotherapy in mice with hepatic cancer. Asian Pacific Journal of Tropical Medicine. 9(11). 1101–1104. 11 indexed citations
20.
Wang, Zhu, Guoxin Hou, & Toby G. Rossman. (1994). Induction of arsenite tolerance and thermotolerance by arsenite occur by different mechanisms.. Environmental Health Perspectives. 102(suppl 3). 97–100. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhimin Fan Breakdown of academic impact, for papers by Muhammad Tufail Breakdown of academic impact, for papers by Fu-Ju Chou Breakdown of academic impact, for papers by Ming You Breakdown of academic impact, for papers by Yongsheng Huang Breakdown of academic impact, for papers by Liming Gui Breakdown of academic impact, for papers by Dimitra Tsavachidou Breakdown of academic impact, for papers by Chenghui Zhou Breakdown of academic impact, for papers by Chee Wai Fhu
Rankless by CCL
2026